According to in silico and ex vivo studies, MCM3AP-AS1, TRAF3IP2-AS1, and IRF1-AS1 expression increased in ALL samples, implying that they may have oncogenic functions. The gene discussed is TRAF3IP2; the disease is acute lymphoblastic leukemia.